UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of WR-2721 in radiotherapy and/or chemotherapy

Cancer clinical trials, 1980, Vol.3 (3), p.211

1980

Volltextzugriff (PDF)

Exposure-response curve for radiation-induced lung tumors in the mouse

Radiation research, 1973-05, Vol.54 (2), p.261

1973

Volltextzugriff (PDF)

Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid

Cancer research (Chicago, Ill.), 1980-05, Vol.40 (5), p.1519-1524

Yuhas, J M

1980

Volltextzugriff (PDF)

A more general role for WR-2721 in cancer therapy

British journal of cancer, 1980-05, Vol.41 (5), p.832-834

Yuhas, J M

1980

Volltextzugriff (PDF)

Misonidazole enhancement of acute and late radiation injury to the rat spinal cord

British journal of cancer, 1979-07, Vol.40 (1), p.161-163

Yuhas, J M

1979

Volltextzugriff (PDF)

Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide

British journal of cancer, 1980-10, Vol.42 (4), p.574-585

1980

Volltextzugriff (PDF)

Response of human neuroblastoma and melanoma multicellular tumor spheroids (MTS) to single dose irradiation

International journal of radiation oncology, biology, physics, 1986-06, Vol.12 (6), p.969-973

1986

Volltextzugriff (PDF)

Quantitation of the response of human tumor spheroids to daily radiation exposures

International journal of radiation oncology, biology, physics, 1984-01, Vol.10 (12), p.2323-2327

1984

Volltextzugriff (PDF)

Recovery from radiation-carcinogenic injury to the mouse ovary

Radiation research, 1974-11, Vol.60 (2), p.321

Yuhas, J M

1974

Volltextzugriff (PDF)

A simplified method for production and growth of multicellular tumor spheroids

Cancer research (Chicago, Ill.), 1977-10, Vol.37 (10), p.3639-3643

1977

Volltextzugriff (PDF)

Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy

Radiation research, 1977-05, Vol.70 (2), p.433

1977

Volltextzugriff (PDF)

Toxicity of WR-2721 administered in single and multiple doses

International journal of radiation oncology, biology, physics, 1984-09, Vol.10 (9), p.1773-1776

1984

Volltextzugriff (PDF)

Induction of spinal cord paralysis by negative pi-mesons

British journal of radiology, 1981-07, Vol.54 (643), p.602-605

1981

Volltextzugriff (PDF)

Differential protection of normal and malignant tissues against the cytotoxic effects of mechlorethamine

Cancer treatment reports, 1979-06, Vol.63 (6), p.971

Yuhas, J M

1979

Volltextzugriff (PDF)

Phase I clinical studies with WR-2721

Cancer clinical trials, 1980, Vol.3 (3), p.217

1980

Volltextzugriff (PDF)

The central nervous system syndrome of the mouse: effects of strain, age, and conditioning exposure

Radiation research, 1968-09, Vol.35 (3), p.714

Yuhas, J M

1968

Volltextzugriff (PDF)

Current status of clinical pion radiotherapy

Radiology, 1977-11, Vol.125 (2), p.489-492

1977

Volltextzugriff (PDF)

Some pharmacologic effects of WR-2721: their role in toxicity and radioprotection

Radiation research, 1973-05, Vol.54 (2), p.222

1973

Volltextzugriff (PDF)

On mouse strain differences in radiation resistance: hematopoietic death and the endogenous colony-forming unit

Radiation research, 1969-09, Vol.39 (3), p.608

1969

Volltextzugriff (PDF)

Efficacy testing of WR-2721 in Great Britain or everything is black and white at the gray lab

International journal of radiation oncology, biology, physics, 1983-04, Vol.9 (4), p.595-598

Yuhas, John M.

1983

Volltextzugriff (PDF)

Final report of the phase I trial of single-dose WR-2721 [S-2-(3-aminopropylamino)ethylphosphorothioic acid]

Cancer treatment reports, 1986-12, Vol.70 (12), p.1389

1986

Volltextzugriff (PDF)

Late effects of unilateral radiation on the mouse kidney

Radiation research, 1978-11, Vol.76 (2), p.429

1978

Volltextzugriff (PDF)

Protective drugs in cancer therapy: Optimal clinical testing and future directions

International journal of radiation oncology, biology, physics, 1982-03, Vol.8 (3), p.513-517

Yuhas, John M.

1982

Volltextzugriff (PDF)

Relative contribution of target cell disturbances and immunosuppression in radiation leukemogenesis: model studies with exogenous virus

Radiation research, 1976-10, Vol.68 (1), p.104

1976

Volltextzugriff (PDF)

Biological factors affecting the radioprotective efficiency of S-2-[2-aminopropylamino] ethylphosphorothioic acid (WR-2721). LD50(3)) doses

Radiation research, 1970-12, Vol.44 (3), p.621

Yuhas, J M

1970

Volltextzugriff (PDF)

1 – 25 von 132

Menü

Weitere Dienste

Einstellungen

The role of WR-2721 in radiotherapy and/or chemotherapy

Exposure-response curve for radiation-induced lung tumors in the mouse

Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid

A more general role for WR-2721 in cancer therapy

Misonidazole enhancement of acute and late radiation injury to the rat spinal cord

Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide

Response of human neuroblastoma and melanoma multicellular tumor spheroids (MTS) to single dose irradiation

Quantitation of the response of human tumor spheroids to daily radiation exposures

Recovery from radiation-carcinogenic injury to the mouse ovary

A simplified method for production and growth of multicellular tumor spheroids

Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy

Toxicity of WR-2721 administered in single and multiple doses

Induction of spinal cord paralysis by negative pi-mesons

Differential protection of normal and malignant tissues against the cytotoxic effects of mechlorethamine

Phase I clinical studies with WR-2721

The central nervous system syndrome of the mouse: effects of strain, age, and conditioning exposure

Current status of clinical pion radiotherapy

Some pharmacologic effects of WR-2721: their role in toxicity and radioprotection

On mouse strain differences in radiation resistance: hematopoietic death and the endogenous colony-forming unit

Efficacy testing of WR-2721 in Great Britain or everything is black and white at the gray lab

Final report of the phase I trial of single-dose WR-2721 [S-2-(3-aminopropylamino)ethylphosphorothioic acid]

Late effects of unilateral radiation on the mouse kidney

Protective drugs in cancer therapy: Optimal clinical testing and future directions

Relative contribution of target cell disturbances and immunosuppression in radiation leukemogenesis: model studies with exogenous virus

Biological factors affecting the radioprotective efficiency of S-2-[2-aminopropylamino] ethylphosphorothioic acid (WR-2721). LD50(3)) doses

Aktive Filter

Suchergebnisse filtern